Research Triangle Park, NC, November 28, 2007 --(PR.com
)-- Dr. William F. Greenlee, president and CEO of The Hamner Institutes For Health Sciences, an independent, nonprofit organization that offers an open, collaborative and cross-disciplinary approach to translational research to enhance the value of the investment in biomedical sciences, has announced that Julianne Hall has joined the organization as a research investigator for the Division of Computational Biology. In this position, Hall will be working in molecular pharmacology conducting breast cancer research. Through this research, she hopes to provide the data necessary for pharmaceutical companies to develop new drugs for the treatment of breast cancer.
Hall, who has been involved with breast cancer research for more than a decade, also currently serves as adjunct assistant professor of biology at Elon University. Past industry-related positions include research scientist and pharmacology junior faculty member at Duke University, as well as a postdoctoral fellow at the National Institute of Environmental Health Sciences (NIEHS). Hall is a member of the American Society for Biochemistry and Molecular Biology (ASBMB), the Federation of American Societies for Experimental Biology (FASEB), the Endocrine Society and Women in Endocrinology.
Hall earned her bachelor’s degree in biology from Trinity College in Hartford, Conn., graduating summa cum lade and valedictorian, and her Ph.D. in pharmacology from Duke University. A native of Connecticut, she resides in Durham, N.C. with her husband, Tom Stanley.
"We are extremely pleased that Dr. Hall has joined the senior scientific staff at The Hamner Institutes,” said Greenlee. “She is a key addition to our emerging cancer biology program focused on the development of novel therapeutic approaches for the detection and treatment of breast and other cancers."
About The Hamner Institutes for Health Sciences:
Located on a 56-acre campus in Research Triangle Park, North Carolina, The Hamner Institutes for Health Sciences is an independent, nonprofit organization that unites academia, the private sector and government to conduct translational research to improve public health and expedite the development of new medicines. With the ultimate goal of preventing and curing disease, The Hamner offers an open, collaborative and cross-disciplinary approach to strengthen the research investment in biomedical sciences. CIIT, the flagship institute for The Hamner, has been recognized for more than 30 years as a leader in research in environmental risk assessment and health sciences. For more information, please visit http://www.thehamner.org or call (919) 558-1200.
MMI Associates, Inc.
PR Firms Raleigh, NC